This is the goal which Neurizon Therapeutics Ltd – the company formerly known as PharmAust – is pursuing through development ...
While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...
Neurizon Therapeutics Limited (Neurizon), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, announced it has received notice of a positive opinion from the European ...
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for ...
Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ...
13d
Clinical-stage biotech Neurizon Therapeutics – formerly PharmAust – made significant strides advancing its treatments for neurodegenerative diseases during the September 2024 quarter.
Neurizon partners with GenieUs for the Phase 1 trial, using genomic profiling to enhance patient stratification and deepen therapeutic insights. SYDNEY, AUSTRALIA, November 7, 2024 /EINPresswire ...
MELBOURNE, Australia, Oct. 15, 2024 /PRNewswire/ -- Neurizon Therapeutics Limited (ASX: NUZ) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to advancing treatments for ...
MELBOURNE, Australia, Nov. 11, 2024 /PRNewswire/ --Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback